Peng Wu

Tianjin, 301600, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Targeting p16INK4a-mediated cellular senescence as a therapeutic strategy for FLT3-ITD-driven acute myeloid leukemia.

Targeting p16INK4a-mediated cellular senescence as a therapeutic strategy for FLT3-ITD-driven acute myeloid leukemia.

Journal: Leukemia
Published: January 26, 2025

Charting epimutation dynamics in human hematopoietic differentiation.

Charting epimutation dynamics in human hematopoietic differentiation.

Journal: Blood science (Baltimore, Md.)
Published: March 31, 2024

Minimal residual disease monitoring in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia: prognostic significance and correlation between multiparameter flow cytometry and real-time quantitative polymerase chain reaction.

Minimal residual disease monitoring in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia: prognostic significance and correlation between multiparameter flow cytometry and real-time quantitative polymerase chain reaction.

Journal: Haematologica
Published: January 22, 2024

Integration of Transcriptomic Features to Improve Prognosis Prediction of Pediatric Acute Myeloid Leukemia With KMT2A Rearrangement.

Integration of Transcriptomic Features to Improve Prognosis Prediction of Pediatric Acute Myeloid Leukemia With KMT2A Rearrangement.

Journal: HemaSphere
Published: March 20, 2023

Clonal evolution dissection reveals that a high MSI2 level promotes chemoresistance in T-cell acute lymphoblastic leukemia.

Clonal evolution dissection reveals that a high MSI2 level promotes chemoresistance in T-cell acute lymphoblastic leukemia.

Journal: Blood
Published: March 16, 2023

Erythroid-intrinsic activation of TLR8 impairs erythropoiesis in inherited anemia.

Erythroid-intrinsic activation of TLR8 impairs erythropoiesis in inherited anemia.

Journal: Nature communications
Published: February 01, 2023

Single-cell analysis of transcription factor regulatory networks reveals molecular basis for subtype-specific dysregulation in acute myeloid leukemia.

Single-cell analysis of transcription factor regulatory networks reveals molecular basis for subtype-specific dysregulation in acute myeloid leukemia.

Journal: Blood science (Baltimore, Md.)
Published: March 10, 2022

FLT3 pathway is a potential therapeutic target for PRC2-mutated T-cell acute lymphoblastic leukemia.

FLT3 pathway is a potential therapeutic target for PRC2-mutated T-cell acute lymphoblastic leukemia.

Journal: Blood
Published: April 16, 2018
Showing 1-8 of 8

Last Updated: 09/26/2026